---
figid: PMC9417543__fmicb-13-963488-g001
figtitle: 'Microbiota and COVID-19: Long-term and complex influencing factors'
organisms:
- Helicobacter pylori
- Clostridioides difficile
- Lactiplantibacillus plantarum
- Lactococcus lactis
- Lacticaseibacillus casei
- Limosilactobacillus reuteri
- Lactobacillus acidophilus
- Staphylococcus epidermidis
- Bifidobacterium longum
- Faecalibacterium prausnitzii
- Lacticaseibacillus rhamnosus
- Lacticaseibacillus rhamnosus GG
- Levilactobacillus brevis
- Bacteroides thetaiotaomicron
- Clostridioides difficile CD3
- Limosilactobacillus fermentum
- Bifidobacterium adolescentis
- Bifidobacterium bifidum
- Burkholderia cepacia
- Bifidobacterium longum subsp. infantis
- Lactobacillus gasseri
- Ruminococcus gnavus
- Phocaeicola vulgatus
- Clostridioides difficile CD8
- Prevotella intermedia
- Eubacterium rectale
- Acinetobacter sp.
- Roseburia intestinalis
- Klebsiella sp.
- Anaerobutyricum hallii
- Lacticaseibacillus casei str. Zhang
- Eggerthella lenta
- Streptococcus sp.
- Pediococcus acidilactici
- Serratia sp. in enterobacteria
- Collinsella aerofaciens
- Metamycoplasma hominis
- Ruminococcus bromii
- Thomasclavelia ramosa
- Haemophilus parainfluenzae
- Hungatella hathewayi
- Blautia obeum
- Lachnospiraceae bacterium
- Bifidobacterium longum subsp. longum
- Lactiplantibacillus plantarum subsp. plantarum
- Parabacteroides merdae
- Streptococcus infantis
- Odoribacter splanchnicus
- Bacteroides stercoris
- Phocaeicola dorei
- Phocaeicola massiliensis
- Prevotella bivia
- Alistipes shahii
- Lachnospira eligens
- Rothia mucilaginosa
- Metamycoplasma orale
- Alistipes onderdonkii
- Burkholderia contaminans
- Collinsella tanakaei
- Campylobacter hominis
- Coprococcus catus
- Streptococcus salivarius K12
- Burkholderiales bacterium
- Peptoniphilus sp.
- Prevotella disiens
- Treponema amylovorum
- Alistipes indistinctus
- Coprobacter fastidiosus
- Serratia sp. SP-1.4
- Bacteroides salyersiae
- Peptoniphilus lacrimalis
- Neisseria perflava
- Saccharomyces cerevisiae
- Solanum tuberosum
- Candida albicans
- herbal medicine
- Cucumis sativus
- Scutellaria baicalensis
- Aspergillus flavus
- Melia azedarach
- Saccharomyces boulardii nom. inval.
- Penicillium citrinum
- Candida auris
- Rhodotorula mucilaginosa
- Moesziomyces aphidis
- Penicillium polonicum
- Malassezia yamatoensis
- Candida albicans DAY25
- Severe acute respiratory syndrome coronavirus 2
- Coronaviridae
- Severe acute respiratory syndrome-related coronavirus
- unidentified influenza virus
- H1N1 subtype
- DNA viruses
- Ebola virus
- Pepper mild mottle virus
- unclassified viruses
- Pepper chlorotic spot virus
- gut metagenome
- metagenome
- human metagenome
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Bacteriophage sp.
- Mustela putorius furo
organisms_ner:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Mustela putorius furo
- Drosophila melanogaster
- Danio rerio
pmcid: PMC9417543
filename: fmicb-13-963488-g001.jpg
figlink: /pmc/articles/PMC9417543/figure/F1/
number: F1
caption: Schematic diagram of the relationships among SARS-CoV-2, ACE2, host immunity,
  and microorganisms. (1) Microbiota metabolites such as butyrate exert anti-inflammatory
  effects by up-regulating arginase 1 (Arg1) expression, down-regulating Nos2, IL6,
  and IL-12, and inhibiting tumor necrosis factor (TNF) activity. In addition, short-chain
  fatty acids inhibit histone deacetylases and increase the expression of foxp3 through
  the GPR43 receptor, thereby enhancing the regulatory function of FOXP3 + Treg cells
  resulting in anti-inflammatory effects. On the other aspect, short-chain fatty acids
  can inhibit TMPRSS2 gene expression and up-regulate antiviral pathways to inhibit
  viral entry. (2) The SARS-CoV-2 is activated by TMPRSS2, binds to ACE2 and enters
  the gut, can destroy the gut barrier and causes microbiota dysbiosis. (3) SARS-CoV-2
  infection suppresses the JAK-STAT pathway of type I and type III interferon responses,
  and the protein encoded by ISGF3 that limits viral infection will be diminished.
  Besides, SARS-CoV-2 infection downregulates the expression of ACE2, weakens its
  ability to regulate the RAS system, and over activates the immune response. Dysregulated
  gut microbes and their metabolites can also stimulate the production of cytokines,
  causing a cytokine storm. (4) SARS-CoV-2 spike protein activates the Ras-Raf-MEK-ERK-VEGF
  pathway in intestinal epithelial cells and promotes vascular endothelial growth
  factor (VEGF) production, which leads to vascular permeability and inflammation.
  (5) ACE2 regulates the expression of the amino acid transporter B0AT1, which affects
  microbiota composition through mTOR-mediated antimicrobial peptide production.
papertitle: 'Microbiota and COVID-19: Long-term and complex influencing factors.'
reftext: Jiaqi Gang, et al. Front Microbiol. 2022;13:963488.
year: '2022'
doi: 10.3389/fmicb.2022.963488
journal_title: Frontiers in Microbiology
journal_nlm_ta: Front Microbiol
publisher_name: Frontiers Media S.A.
keywords: COVID-19 | SARS-CoV-2 | microbiota | ACE2 | diagnostic model | microbiota
  transplantation | traditional Chinese medicine
automl_pathway: 0.6960462
figid_alias: PMC9417543__F1
figtype: Figure
redirect_from: /figures/PMC9417543__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9417543__fmicb-13-963488-g001.html
  '@type': Dataset
  description: Schematic diagram of the relationships among SARS-CoV-2, ACE2, host
    immunity, and microorganisms. (1) Microbiota metabolites such as butyrate exert
    anti-inflammatory effects by up-regulating arginase 1 (Arg1) expression, down-regulating
    Nos2, IL6, and IL-12, and inhibiting tumor necrosis factor (TNF) activity. In
    addition, short-chain fatty acids inhibit histone deacetylases and increase the
    expression of foxp3 through the GPR43 receptor, thereby enhancing the regulatory
    function of FOXP3 + Treg cells resulting in anti-inflammatory effects. On the
    other aspect, short-chain fatty acids can inhibit TMPRSS2 gene expression and
    up-regulate antiviral pathways to inhibit viral entry. (2) The SARS-CoV-2 is activated
    by TMPRSS2, binds to ACE2 and enters the gut, can destroy the gut barrier and
    causes microbiota dysbiosis. (3) SARS-CoV-2 infection suppresses the JAK-STAT
    pathway of type I and type III interferon responses, and the protein encoded by
    ISGF3 that limits viral infection will be diminished. Besides, SARS-CoV-2 infection
    downregulates the expression of ACE2, weakens its ability to regulate the RAS
    system, and over activates the immune response. Dysregulated gut microbes and
    their metabolites can also stimulate the production of cytokines, causing a cytokine
    storm. (4) SARS-CoV-2 spike protein activates the Ras-Raf-MEK-ERK-VEGF pathway
    in intestinal epithelial cells and promotes vascular endothelial growth factor
    (VEGF) production, which leads to vascular permeability and inflammation. (5)
    ACE2 regulates the expression of the amino acid transporter B0AT1, which affects
    microbiota composition through mTOR-mediated antimicrobial peptide production.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ARG1
  - TINAGL1
  - FOXP3
  - FFAR2
  - COX1
  - TMPRSS2
  - ACE2
  - IFNA1
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - ATXN1L
  - SLC6A19
  - IL6
  - MTOR
  - CCL2
  - ADSL
  - CXCL8
  - Gusb
  - Arg1
  - Tinagl1
  - Foxp3
  - Ffar2
  - Tmprss2
  - Ace2
  - Zhx2
  - Mdk
  - Ephb2
  - Mapk1
  - Apc
  - Il6
  - Mtor
  - Mcpt1
  - Ccl2
  - Cxcl15
  - Ephb1
  - Slc6a19
  - Ubc7
  - kn
  - crl
  - coi
  - Curl
  - Ace
  - bub
  - Raf
  - Dsor1
  - Mtk
  - Erk7
  - rl
  - E(spl)malpha-BFM
  - min
  - mnb
  - .na.character
  - Tor
  - arg1
  - foxp3a
  - tmprss2
  - ace2
  - ifnphi1
  - il6
  - mtor
  - cxcl8a
---
